Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Viemed Healthcare Inc., 3 years.
Viemed Healthcare Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | Viemed Healthcare Inc. | Option exercise | +15,029 | — | — |
| Aug 19, 2026 | Viemed Healthcare Inc. | Option exercise | +3,757 | — | — |
| Aug 19, 2026 | Viemed Healthcare Inc. | Sold back to the company | −3,757 | $8.94 | $33,588 |
| Jun 24, 2026 | Viemed Healthcare Inc. | Open-market sale | −1,636 | $11.48 | $18,781 |
| Jun 24, 2026 | Viemed Healthcare Inc. | Open-market sale | −3,364 | $11.50 | $38,686 |
| Jun 24, 2026 | Viemed Healthcare Inc. | Open-market sale | −5,000 | $11.56 | $57,800 |
| Jun 24, 2026 | Viemed Healthcare Inc. | Open-market sale | −5,000 | $11.53 | $57,650 |
| Jun 24, 2026 | Viemed Healthcare Inc. | Open-market sale | −5,000 | $11.41 | $57,050 |
| Aug 20, 2025 | Viemed Healthcare Inc. | Option exercise | +15,732 | — | — |
| Mar 14, 2025 | Viemed Healthcare Inc. | Open-market sale | −3,000 | $7.73 | $23,190 |
| Mar 13, 2025 | Viemed Healthcare Inc. | Open-market sale | −4,200 | $7.70 | $32,340 |
| Mar 13, 2025 | Viemed Healthcare Inc. | Open-market sale | −2,000 | $7.69 | $15,380 |
| Mar 13, 2025 | Viemed Healthcare Inc. | Open-market sale | −2,000 | $7.65 | $15,300 |
| Mar 13, 2025 | Viemed Healthcare Inc. | Open-market sale | −665 | $7.75 | $5,154 |
| Aug 25, 2024 | Viemed Healthcare Inc. | Option exercise | +10,719 | — | — |
Questions about Timothy Smokoff
What boards is Timothy Smokoff on?
Timothy Smokoff sits on the board of Viemed Healthcare Inc.
How long has Timothy Smokoff served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.